Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Studies of dermatologic agents from Barrier presented at AAD conference

Feb. 12, 2007

Recent Aditech patent announces novel antipsoriatic agents

Feb. 12, 2007

Bicyclic monoterpene diol mixture may be useful to repair photodamaged skin

Feb. 9, 2007

Alefacept active, well tolerated in atopic dermatitis

Feb. 9, 2007

AN-2728: a novel antipsoriatic profiled at Anacor

Feb. 8, 2007

Avocado extract shows in vitro activity against skin fungal pathogens

Feb. 8, 2007

New phase II trial for prostaglandin derivative JB-991

Feb. 7, 2007

Dimericine(TM) may ameliorate UVB-induced DNA damage

Feb. 7, 2007

Case studies demonstrate activity of efalizumab in dermatologic diseases

Feb. 7, 2007

BioXell exercises option to Roche compound

Feb. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...